Bill
Emergency Administration of Epinephrine Amendments
- Number
- S.B. 108 (2017GS)
- Sponsor
- Sen. Shiozawa, B.
- Final action
- Governor Signed 3/17/2017
- Outcome
- Became law — signed by Gov. Gary R. Herbert
Summary
This bill amends the Emergency Injection for Anaphylactic Reaction Act.
What it does
- This bill:
- amends the definition of epinephrine auto-injector to allow the use of more than one manufacturer of a device.
Every vote on this bill
1/31/2017Senate Comm - Favorable Recommendation
Senate Health and Human Services Committee
5 0 3not eligible / no record2/15/2017Senate/ passed 2nd reading
Senate 3rd Reading Calendar
26 0 3not eligible / no record2/17/2017Senate/ passed 3rd reading
Clerk of the House
26 0 3not eligible / no record2/27/2017House Comm - Favorable Recommendation
House Health and Human Services Committee
10 0 2YEA2/27/2017House Comm - Consent Calendar Recommendation
House Health and Human Services Committee
10 0 2YEA3/2/2017House/ passed 3rd reading
House Speaker
66 0 9YEABill text
introduced version · official source
EMERGENCY ADMINISTRATION OF EPINEPHRINE AMENDMENTS GENERAL SESSION STATE OF UTAH Chief Sponsor: Brian E. Shiozawa House Sponsor: Edward H. Redd LONG TITLE General Description: This bill amends the Emergency Injection for Anaphylactic Reaction Act. Highlighted Provisions: This bill: ▸ amends the definition of epinephrine auto-injector to allow the use of more than one manufacturer of a device. Money Appropriated in this Bill: None Other Special Clauses: None Utah Code Sections Affected: AMENDS: 26-41-102 , as last amended by Laws of Utah 2015, Chapter 332 Be it enacted by the Legislature of the state of Utah: Section 1. Section 26-41-102 is amended to read: 26-41-102. Definitions. As used in this chapter: (1) "Anaphylaxis" means a potentially life-threatening hypersensitivity to a substance. (a) Symptoms of anaphylaxis may include shortness of breath, wheezing, difficulty breathing, difficulty talking or swallowing, hives, itching, swelling, shock, or asthma. (b) Causes of anaphylaxis may include insect sting, food allergy, drug reaction, and exercise. (2) "Epinephrine auto-injector" means a portable, disposable drug delivery [ system with a spring-activated concealed needle that is designed for emergency administration of epinephrine to provide rapid, convenient first-aid for persons ] device that contains a measured, single dose of epinephrine that is used to treat a person suffering a potentially fatal anaphylactic reaction. (3) "Qualified adult" means a person who: (a) is 18 years of age or older; and (b) has successfully completed the training program established in Section 26-41-104 . (4) "Qualified entity": (a) means a facility or organization that employs, contracts with, or has a similar relationship with a qualified adult who is likely to have contact with another person who may experience anaphylaxis; and (b) includes: (i) recreation camps; (ii) an education facility, school, or university; (iii) a day care facility; (iv) youth sports leagues; (v) amusement parks; (vi) food establishments; (vii) places of employment; and (viii) recreation areas. Legislative Review Note Office of Legislative Research and General Counsel